• PR-619: Deubiquitylating Enzymes Inhibitor for Workflow Mast

  2026-06-29

  PR-619 stands out as a broad-spectrum, reversible deubiquitylating enzymes inhibitor, providing researchers unparalleled control over cellular ubiquitination pathways. Its robust, cell-permeable profile and nuanced selectivity empower advanced cancer and neurodegeneration models, while its practical solubility and workflow adaptability set it apart from traditional proteasome inhibitors.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-06-28

  Erastin, a benchmark ferroptosis inducer from APExBIO, enables highly selective, iron-dependent cell death in RAS/BRAF-mutant tumor models. This article delivers optimized protocols, practical troubleshooting, and data-driven insights to accelerate ferroptosis research and uncover tumor vulnerabilities.

• Erastin: Benchmark Ferroptosis Inducer for Cancer Biology

  2026-06-27

  Erastin is a validated small molecule ferroptosis inducer that selectively triggers iron-dependent, non-apoptotic cell death in RAS or BRAF mutant tumor cells. Its mechanism involves inhibition of the cystine/glutamate antiporter system Xc⁻ and modulation of mitochondrial VDAC, leading to cellular oxidative stress. This article details Erastin's evidence base, workflow parameters, and practical applications in ferroptosis and cancer biology research.

• Fisetin Inhibits Ferroptosis to Protect Against Traumatic Br

  2026-06-26

  Yang et al. (2024) demonstrate that fisetin exerts neuroprotective effects after traumatic brain injury (TBI) by inhibiting ferroptosis and oxidative stress pathways in both in vivo and in vitro models. This study provides mechanistic insight into the regulation of iron-dependent cell death in TBI and highlights the relevance of ferroptosis in secondary neural injury.

• NBC19: Advanced NLRP3 Inflammasome Inhibitor for Inflammatio

  2026-06-26

  NBC19 enables reproducible, high-sensitivity inhibition of the NLRP3 inflammasome, delivering robust suppression of IL-1β release in diverse inflammation models. This article decodes practical workflows, links cutting-edge sepsis research to inflammasome study design, and provides actionable troubleshooting guidance for maximizing experimental success.

• E-64: L-trans-Epoxysuccinyl Peptide for Precision Protease I

  2026-06-25

  E-64's irreversible, nanomolar-range inhibition of cysteine proteases empowers researchers to dissect cathepsin- and calpain-driven pathways with exceptional reproducibility. Its superior solubility and workflow versatility, as demonstrated in both mechanistic and translational studies, make E-64 a cornerstone for advanced cancer and cell signaling research.

• Nuclear cGAS Restricts L1 Retrotransposition via TRIM41 Path

  2026-06-25

  This study uncovers a posttranslational mechanism by which nuclear cGAS represses LINE-1 (L1) retrotransposition through TRIM41-mediated degradation of ORF2p, thereby preserving genome stability. These findings connect DNA damage response, innate immunity, and transposable element control, with implications for aging and cancer biology.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-06-24

  The reference study identifies moesin (MSN) as a novel, quantifiable biomarker directly linked to endothelial injury and disease severity in sepsis. By elucidating the mechanistic connection between MSN expression, vascular permeability, and inflammatory signaling, this work provides a new molecular handle for both basic and translational sepsis research.

• AM 281: Precision CB1 Cannabinoid Receptor Antagonist for TB

  2026-06-23

  AM 281 enables researchers to dissect CB1-CREB-GLT-1 signaling in traumatic brain injury and cognitive dysfunction models with high selectivity and reproducibility. Its performance in modulating memory impairment and neuroprotection pathways distinguishes it as a cornerstone for translational neuropharmacology studies.

• Practical Use of Cy5 Maleimide (Non-sulfonated) for Protein

  2026-06-23

  Cy5 maleimide (non-sulfonated) enables selective, site-specific fluorescent labeling of proteins and peptides through thiol groups—solving challenges in quantitative imaging and probe generation. It is optimal for workflows requiring high-purity, stable thioether conjugates, but requires careful solvent handling due to low water solubility. This reagent is not recommended for labeling in strongly aqueous-only systems or where non-thiol selectivity is desired.

• Optimizing mRNA Lipoplex Transfection: TC-1-12 Lipid Innovat

  2026-06-22

  This study introduces a streamlined, highly efficient method for mRNA transfection into tumor cells using TC-1-12-based lipoplexes prepared via a modified ethanol injection (MEI) technique. The findings reveal superior protein expression, improved mRNA uptake, and practical storage benefits, informing future design of mRNA delivery systems for research and therapeutic applications.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Lab G

  2026-06-22

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses proteolytic degradation during protein extraction, sample preparation, and downstream analytical workflows. Its EDTA-free formulation permits use in divalent cation-sensitive assays, such as phosphorylation analysis. Not suitable for workflows explicitly requiring metalloprotease inhibition by chelation.

• Fisetin Mitigates Ferroptosis and Oxidative Stress After TBI

  2026-06-21

  Yang et al. provide compelling evidence that fisetin, a natural flavonoid, exerts neuroprotective effects in traumatic brain injury (TBI) by suppressing ferroptosis and oxidative damage. Their integrated in vivo and in vitro model demonstrates that regulating ferroptosis via the PI3K/AKT/NRF2 pathway is a promising strategy for limiting neuronal loss and cognitive dysfunction after TBI.

• Dihydroethidium: Shaping Translational Redox Biology Strateg

  2026-06-20

  This thought-leadership article dissects how Dihydroethidium (DHE)—a gold-standard probe for superoxide anion detection—empowers translational researchers to unravel oxidative stress mechanisms at the cellular and disease level. By integrating mechanistic insights, competitive benchmarking, and strategic workflow guidance, it bridges foundational redox biology with actionable translational impact. Drawing on recent research and cross-referencing existing content, we clarify DHE’s pivotal role in advancing oxidative stress assays across aging, cardiovascular disease, and apoptosis research.

• Erastin: Applied Ferroptosis Inducer for Cancer Biology Rese

  2026-06-19

  Erastin enables precise induction of ferroptosis in RAS/BRAF-mutant tumor cells, making it indispensable for dissecting oxidative cell death mechanisms in cancer biology research. This article delivers actionable experimental workflows, troubleshooting insights, and integration of recent breakthroughs for researchers seeking robust, reproducible ferroptosis assays.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page